The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion.

Clicks: 217
ID: 20816
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #100 of 438 articles by views in acta neuropathologica

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 438 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Apart from amyloid β deposition and tau neurofibrillary tangles, Alzheimer's disease (AD) is a neurodegenerative disorder characterized by neuronal loss and astrocytosis in the cerebral cortex. The goal of this study is to investigate genetic factors associated with the neuronal proportion in health and disease. To identify cell-autonomous genetic variants associated with neuronal proportion in cortical tissues, we inferred cellular population structure from bulk RNA-Seq derived from 1536 individuals. We identified the variant rs1990621 located in the TMEM106B gene region as significantly associated with neuronal proportion (p value = 6.40 × 10) and replicated this finding in an independent dataset (p value = 7.41 × 10) surpassing the genome-wide threshold in the meta-analysis (p value = 9.42 × 10). This variant is in high LD with the TMEM106B non-synonymous variant p.T185S (rs3173615; r = 0.98) which was previously identified as a protective variant for frontotemporal lobar degeneration (FTLD). We stratified the samples by disease status, and discovered that this variant modulates neuronal proportion not only in AD cases, but also several neurodegenerative diseases and in elderly cognitively healthy controls. Furthermore, we did not find a significant association in younger controls or schizophrenia patients, suggesting that this variant might increase neuronal survival or confer resilience to the neurodegenerative process. The single variant and gene-based analyses also identified an overall genetic association between neuronal proportion, AD and FTLD risk. These results suggest that common pathways are implicated in these neurodegenerative diseases, that implicate neuronal survival. In summary, we identified a protective variant in the TMEM106B gene that may have a neuronal protection effect against general aging, independent of disease status, which could help elucidate the relationship between aging and neuronal survival in the presence or absence of neurodegenerative disorders. Our findings suggest that TMEM106B could be a potential target for neuronal protection therapies to ameliorate cognitive and functional deficits.
Reference Key
li2019theacta Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Li, Zeran;Farias, Fabiana H G;Dube, Umber;Del-Aguila, Jorge L;Mihindukulasuriya, Kathie A;Fernandez, Maria Victoria;Ibanez, Laura;Budde, John P;Wang, Fengxian;Lake, Allison M;Deming, Yuetiva;Perez, James;Yang, Chengran;Bahena, Jorge A;Qin, Wei;Bradley, Joseph L;Davenport, Richard;Bergmann, Kristy;Morris, John C;Perrin, Richard J;Benitez, Bruno A;Dougherty, Joseph D;Harari, Oscar;Cruchaga, Carlos;
Journal acta neuropathologica
Year 2019
DOI
10.1007/s00401-019-02066-0
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.